ArrayExpress Uploader0humanglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformetemozolomide and radiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapyglioblastoma multiformeradiotherapynormalnot availablenormalnot availablenormalnot availablenormalnot availablerecurrent glioblastoma multiformetemozolomide and radiotherapyrecurrent glioblastoma multiformetemozolomide and radiotherapyrecurrent glioblastoma multiformetemozolomide and radiotherapyrecurrent glioblastoma multiformetemozolomide and radiotherapyrecurrent glioblastoma multiformetemozolomide and radiotherapyrecurrent glioblastoma multiformetemozolomide and radiotherapyrecurrent glioblastoma multiformetemozolomide and radiotherapyrecurrent glioblastoma multiformetemozolomide and radiotherapyrecurrent glioblastoma multiformetemozolomide and radiotherapyrecurrent glioblastoma multiformeradiotherapy4926arrayexpress_sid4Analysis of 80 glioblastoma specimen of patients treated within clinical trials and 4 samples of "normal" brain tissue (non-tumoral)....E-GEOD-7696/profile/8773/arrayexpressuploader284brainDec.12, 2014Falsetranscription-profiling-by-array-of-human-gliobl-7E-GEOD-7696_A-AFFY-44Transcription profiling by array of human glioblastoma samples after radiotherapy and/or temonzolomideSep.22, 2014Analysis of 80 glioblastoma specimen of patients treated within clinical trials and 4 samples of "normal" brain tissue (non-tumoral). The data was used to identify factors of resistance to a chemoradiation therapy protocol of radiotherapy and concomitant and adjuvant temozolomide (alkylating agent). Experiment Overall Design: 80 glioblastoma specimen and 4 non-tumoral brain sampleshttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-7696http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-7696/samples/